These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34273359)

  • 21. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
    Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
    Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndrome.
    de P S Soares R; Maeda NY; Bydlowski SP; Lopes AA
    Cardiol Young; 2005 Oct; 15(5):504-13. PubMed ID: 16164790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy.
    Liu ZH; Wei R; Wu YP; Lisman T; Wang ZX; Han JJ; Ren DL; Chen B; Xia ZL; Chen B; Zhu Z; Zhang Y; Cui X; Hu HT; de Groot PG; Xu WB
    Biomed Environ Sci; 2005 Aug; 18(4):260-4. PubMed ID: 16274108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial dysfunction associated with chronic intravascular coagulation in secondary pulmonary hypertension.
    Lopes AA; Caramurú LH; Maeda NY
    Clin Appl Thromb Hemost; 2002 Oct; 8(4):353-8. PubMed ID: 12516685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection.
    Francischetti IMB; Toomer K; Zhang Y; Jani J; Siddiqui Z; Brotman DJ; Hooper JE; Kickler TS
    EClinicalMedicine; 2021 Sep; 39():101069. PubMed ID: 34377969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased levels of endothelial haemostatic markers in patients with coronary heart disease.
    Schumacher A; Seljeflot I; Sommervoll L; Christensen B; Otterstad JE; Arnesen H
    Thromb Res; 2002 Jan; 105(1):25-31. PubMed ID: 11864703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.
    Wållberg-Jonsson S; Dahlén GH; Nilsson TK; Rånby M; Rantapää-Dahlqvist S
    Clin Rheumatol; 1993 Sep; 12(3):318-24. PubMed ID: 8258230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation.
    Zhang J; Xue M; Chen Y; Liu C; Kuang Z; Mu S; Wei W; Yin J; Xiang H; Hu Y; Long X; Fang S; Sun S; Wang B; Tong C; Song Z
    Ann Palliat Med; 2021 Oct; 10(10):10170-10184. PubMed ID: 34551574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.
    Philippe A; Chocron R; Gendron N; Bory O; Beauvais A; Peron N; Khider L; Guerin CL; Goudot G; Levasseur F; Peronino C; Duchemin J; Brichet J; Sourdeau E; Desvard F; Bertil S; Pene F; Cheurfa C; Szwebel TA; Planquette B; Rivet N; Jourdi G; Hauw-Berlemont C; Hermann B; Gaussem P; Mirault T; Terrier B; Sanchez O; Diehl JL; Fontenay M; Smadja DM
    Angiogenesis; 2021 Aug; 24(3):505-517. PubMed ID: 33449299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns.
    Aoki K; Aikawa N; Sekine K; Yamazaki M; Mimura T; Urano T; Takada A
    Burns; 2001 Sep; 27(6):569-75. PubMed ID: 11525850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus].
    Galajda P; Martinka E; Baláz D; Stasko J; Kerný J; Planková E; Mokán M; Kubisz P
    Vnitr Lek; 1997 Nov; 43(11):744-7. PubMed ID: 9650506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Schönlein purpura.
    Besbas N; Erbay A; Saatçi U; Ozdemir S; Bakkaloglu A; Ozen S; Topaloglu R
    Clin Exp Rheumatol; 1998; 16(1):95-8. PubMed ID: 9543574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.
    Segarra A; Chacón P; Martinez-Eyarre C; Argelaguer X; Vila J; Ruiz P; Fort J; Bartolomé J; Camps J; Moliner E; Pelegrí A; Marco F; Olmos A; Piera L
    J Am Soc Nephrol; 2001 Jun; 12(6):1255-1263. PubMed ID: 11373350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis.
    Lip GY; Blann AD; Jones AF; Beevers DG
    Am Heart J; 1997 Oct; 134(4):764-71. PubMed ID: 9351746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
    Marco A; Marco P
    J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
    Hagag AA; Abdel-Lateef AE; Aly R
    J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium-derived haemostatic factors and the antiphospholipid syndrome.
    Mackworth-Young CG; Andreotti F; Harmer I; Loizou S; Pottinger BE; Pearson JD; Davies GJ; Maseri A; Walport MJ
    Br J Rheumatol; 1995 Mar; 34(3):201-6. PubMed ID: 7728392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monitoring of endothelial activation markers during physiological pregnancy].
    Procházková J; Dhaifallah I; Mechurová A; Pilka R; Simetka O; Slavík L; Ulehlová J; Lubuský M; Procházka M
    Ceska Gynekol; 2010 Apr; 75(2):92-100. PubMed ID: 20518260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.